Jean L Raphael1, Troy Richardson2, Matt Hall2, Suzette O Oyeku3, David G Bundy4, Ram V Kalpatthi5, Samir S Shah6, Angela M Ellison7. 1. Department of Pediatrics, Baylor College of Medicine, Houston, TX. Electronic address: Raphael@bcm.edu. 2. Children's Hospital Association, Overland Park, KS. 3. Department of Pediatrics, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY. 4. Department of Pediatrics, Medical University of South Carolina, Charleston, SC. 5. Department of Pediatrics, The Children's Mercy Hospital and Clinics, Kansas City, MO. 6. Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. 7. Department of Pediatrics, Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA.
Abstract
OBJECTIVE: To assess the relationship between hospital volume and intensive care unit (ICU) transfer among hospitalized children with sickle cell disease (SCD). STUDY DESIGN: We conducted a retrospective cohort study of 83,477 SCD-related hospitalizations at children's hospitals (2009-2012) using the Pediatric Health Information System database. Hospital-level all-cause and SCD-specific volumes were dichotomized (low vs high). Outcomes were within-hospital ICU transfer (primary) and length of stay (LOS) total (secondary). Multivariable logistic/linear regressions assessed the association of hospital volumes with ICU transfer and LOS. RESULTS: Of 83,477 eligible hospitalizations, 1741 (2.1%) involving 1432 unique children were complicated by ICU transfer. High SCD-specific volume (OR 0.77, 95% CI 0.64-0.91) was associated with lower odds of ICU transfer while high all-cause hospital volume was not (OR 0.87, 95% CI 0.73-1.04). A statistically significant interaction was found between all-cause and SCD-specific volumes. When results were stratified according to all-cause volume, high SCD-specific volume was associated with lower odds of ICU transfer at low all-cause volume (OR 0.46, 95% CI 0.38-0.55). High hospital volumes, both all-cause (OR 0.94, 95% CI 0.92-0.97) and SCD-specific (OR 0.86, 95% CI 0.84-0.88), were associated with shorter LOS. CONCLUSIONS: Children's hospitals vary substantially in their transfer of children with SCD to the ICU according to hospital volumes. Understanding the practices used by different institutions may help explain the variability in ICU transfer among hospitals caring for children with SCD.
OBJECTIVE: To assess the relationship between hospital volume and intensive care unit (ICU) transfer among hospitalized children with sickle cell disease (SCD). STUDY DESIGN: We conducted a retrospective cohort study of 83,477 SCD-related hospitalizations at children's hospitals (2009-2012) using the Pediatric Health Information System database. Hospital-level all-cause and SCD-specific volumes were dichotomized (low vs high). Outcomes were within-hospital ICU transfer (primary) and length of stay (LOS) total (secondary). Multivariable logistic/linear regressions assessed the association of hospital volumes with ICU transfer and LOS. RESULTS: Of 83,477 eligible hospitalizations, 1741 (2.1%) involving 1432 unique children were complicated by ICU transfer. High SCD-specific volume (OR 0.77, 95% CI 0.64-0.91) was associated with lower odds of ICU transfer while high all-cause hospital volume was not (OR 0.87, 95% CI 0.73-1.04). A statistically significant interaction was found between all-cause and SCD-specific volumes. When results were stratified according to all-cause volume, high SCD-specific volume was associated with lower odds of ICU transfer at low all-cause volume (OR 0.46, 95% CI 0.38-0.55). High hospital volumes, both all-cause (OR 0.94, 95% CI 0.92-0.97) and SCD-specific (OR 0.86, 95% CI 0.84-0.88), were associated with shorter LOS. CONCLUSIONS:Children's hospitals vary substantially in their transfer of children with SCD to the ICU according to hospital volumes. Understanding the practices used by different institutions may help explain the variability in ICU transfer among hospitals caring for children with SCD.
Authors: Mark I Neuman; Matthew Hall; James C Gay; Anne J Blaschke; Derek J Williams; Kavita Parikh; Adam L Hersh; Thomas V Brogan; Jeffrey S Gerber; Carlos G Grijalva; Samir S Shah Journal: Pediatrics Date: 2014-07 Impact factor: 7.124
Authors: Jean L Raphael; Patricia L Kavanagh; C Jason Wang; Brigitta U Mueller; Barry Zuckerman Journal: Pediatr Blood Cancer Date: 2011-02-22 Impact factor: 3.167
Authors: Jay G Berry; Sara L Toomey; Alan M Zaslavsky; Ashish K Jha; Mari M Nakamura; David J Klein; Jeremy Y Feng; Shanna Shulman; Vincent W Chiang; Vincent K Chiang; William Kaplan; Matt Hall; Mark A Schuster Journal: JAMA Date: 2013-01-23 Impact factor: 56.272
Authors: Romana Hasnain-Wynia; David W Baker; David Nerenz; Joe Feinglass; Anne C Beal; Mary Beth Landrum; Raj Behal; Joel S Weissman Journal: Arch Intern Med Date: 2007-06-25
Authors: Ciaran S Phibbs; Laurence C Baker; Aaron B Caughey; Beate Danielsen; Susan K Schmitt; Roderic H Phibbs Journal: N Engl J Med Date: 2007-05-24 Impact factor: 91.245
Authors: David G Bundy; Troy E Richardson; Matthew Hall; Jean L Raphael; David C Brousseau; Staci D Arnold; Ram V Kalpatthi; Angela M Ellison; Suzette O Oyeku; Samir S Shah Journal: JAMA Pediatr Date: 2017-11-01 Impact factor: 16.193
Authors: Deborah Lubeck; Irene Agodoa; Nickhill Bhakta; Mark Danese; Kartik Pappu; Robin Howard; Michelle Gleeson; Marc Halperin; Sophie Lanzkron Journal: JAMA Netw Open Date: 2019-11-01